Relationship between proteolytic enzyme activity and oxidative stress in subjects with diabetes

The manuscript entitled “oxidative stress and proteolytic activity in erythrocytes of diabetic patients” by varashree and gopalakrishna (1) investigates the relationship between proteolytic enzyme activity and oxidative stress in subjects with diabetes. the results indicate that both erythrocyte malondialdehyde (mda) levels and erythrocyte proteolytic activity were higher in diabetes patients than in control subjects (4.7 ± 1.7 nm/ghb v 3.3 ± 2.2 nm/ghb; p = 0.001 and 167.2 ± 648 nm/ghb v 27.9 ± 31.7 nm/ghb; p = 0.001, respectively). the study is interesting and adds more information to the available literature on plasma biomarkers of oxidative stress. we would, however, highlight some areas of the study that seem to require clarification. first, in regard to the study sample, there is no mention of the type of diabetes that the subjects have. judging by the ages of the patients, it seems likely that the majority would have type 2 diabetes melli (t2dm). additionally, no documentation is made of the therapies used to control glucose and other baseline characteristics such as the duration of diabetes, bmi, presence of micro- or macrovascular complications, blood pressure, and other medications such as ace inhibitors, statins, and aspirin, all of which could play a fundamental role in modifying the generation of reactive oxygen species (ros). moreover, no environmental factors such as smoking status, chd status, or ethnicity are listed, all of which could contribute to increased ros and cellular damage independently of diabetic status. the lack of information regarding insulin usage and dosage should be examined, especially given that reports suggest that insulin can simulate signal transduction pathways in erythrocytes that inhibit atp release from the cell, thereby altering its energy output and ros potential (2).